Wolverine Trading’s Immunic IMUX Stock Holding History

Wolverine Trading’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,990	Closed	-$56K	–	4563
2022 Q4	$56K	Buy	+3,990	New	+$109K	﹤0.01%	3558
2022 Q2	–	Sell	-2,190	Closed	-$253K	–	5078
2022 Q1	$253K	Buy	2,190 +990	+83%	+$115K	﹤0.01%	4119
2021 Q4	$115K	Sell	1,200 -2,090	-64%	-$188K	﹤0.01%	5039
2021 Q3	$299K	Buy	3,290 +820	+33%	+$80.7K	﹤0.01%	4710
2021 Q2	$303K	Buy	+2,470	New	+$342K	﹤0.01%	4409

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's IMUX Position: Q3 2025 in Review

Wolverine Trading opened a new position in Immunic (IMUX) in Q3 2025: 1,095 shares worth $10.2K. The stake represents ﹤0.01% of the portfolio and ranks #5556 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in IMUX as recently as Q4 2024.

Wolverine Trading first reported a position in IMUX in Q4 2021 and has held it in 7 quarters since. The position peaked at $132K in Q1 2022. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.

Wolverine Trading held 1,095 shares of Immunic worth $10.2K as of Q3 2025.
Immunic was a new Wolverine Trading position in Q3 2025.
Immunic made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #5556 holding.
Wolverine Trading first reported a position in Immunic in Q4 2021 and has held it in 7 quarters since.
Wolverine Trading's Immunic position peaked at $132K in Q1 2022.
59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.